Based on our deep science and focused on patients in need.
AvenCell has raised $40.0M in total funding. The most recent round was Grant. The last funding was announced in June 2025.
AvenCell's investors include Novo Holdings, F-Prime, Blackstone Life Sciences, Piper Heartland Healthcare Capital, NYBC Ventures.
AvenCell is headquartered in Watertown, United States.
Based on our deep science and focused on patients in need.
AvenCell is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AvenCell — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/avencell. Accessed September 16, 2026.
VCBacked. (2025). AvenCell — Funding & Investors. Retrieved September 16, 2026, from https://www.vcbacked.co/company/avencell
{{cite web |title=AvenCell — Funding & Investors |url=https://www.vcbacked.co/company/avencell |website=VCBacked |access-date=September 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated